SK286752B6 - Matricová tableta na predĺžené uvoľňovanie trimetazidínu a spôsob jej prípravy - Google Patents
Matricová tableta na predĺžené uvoľňovanie trimetazidínu a spôsob jej prípravy Download PDFInfo
- Publication number
- SK286752B6 SK286752B6 SK863-2002A SK8632002A SK286752B6 SK 286752 B6 SK286752 B6 SK 286752B6 SK 8632002 A SK8632002 A SK 8632002A SK 286752 B6 SK286752 B6 SK 286752B6
- Authority
- SK
- Slovakia
- Prior art keywords
- matrix tablet
- tablet according
- matrix
- trimethazidine
- total weight
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9915960A FR2802424B1 (fr) | 1999-12-17 | 1999-12-17 | Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale |
PCT/FR2000/003546 WO2001043747A1 (fr) | 1999-12-17 | 2000-12-15 | Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale |
Publications (2)
Publication Number | Publication Date |
---|---|
SK8632002A3 SK8632002A3 (en) | 2002-10-08 |
SK286752B6 true SK286752B6 (sk) | 2009-04-06 |
Family
ID=9553398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK863-2002A SK286752B6 (sk) | 1999-12-17 | 2000-12-15 | Matricová tableta na predĺžené uvoľňovanie trimetazidínu a spôsob jej prípravy |
Country Status (33)
Country | Link |
---|---|
EP (1) | EP1108424B2 (sl) |
JP (2) | JP2001172181A (sl) |
KR (1) | KR100456933B1 (sl) |
CN (1) | CN1166408C (sl) |
AR (1) | AR026968A1 (sl) |
AT (1) | ATE296622T1 (sl) |
AU (1) | AU780011B2 (sl) |
BG (1) | BG65773B1 (sl) |
BR (1) | BR0005915A (sl) |
CY (1) | CY2347B1 (sl) |
CZ (1) | CZ299461B6 (sl) |
DE (1) | DE60020501T3 (sl) |
DK (1) | DK1108424T4 (sl) |
EA (2) | EA008223B1 (sl) |
ES (2) | ES2240033T5 (sl) |
FR (1) | FR2802424B1 (sl) |
GE (1) | GEP20053540B (sl) |
GR (1) | GR1003658B (sl) |
HK (1) | HK1036937A1 (sl) |
HU (1) | HU226956B1 (sl) |
IE (1) | IE20001017A1 (sl) |
IT (1) | IT1317075B1 (sl) |
LU (1) | LU90700B1 (sl) |
MX (1) | MXPA00012462A (sl) |
NZ (1) | NZ508912A (sl) |
OA (1) | OA12121A (sl) |
PL (1) | PL206994B1 (sl) |
PT (2) | PT1108424E (sl) |
SI (1) | SI1108424T2 (sl) |
SK (1) | SK286752B6 (sl) |
UA (1) | UA80087C2 (sl) |
WO (1) | WO2001043747A1 (sl) |
ZA (1) | ZA200007548B (sl) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE442852T1 (de) * | 2000-10-05 | 2009-10-15 | Usv Ltd | Trimetazidine enthaltendes arzneimittel mit verzögerter wirkstoffabgabe und verfahren zur herstellung |
KR101175816B1 (ko) * | 2003-08-04 | 2012-08-24 | 교린 세이야꾸 가부시키 가이샤 | 경구 서방성 정제 |
SG126792A1 (en) * | 2005-04-27 | 2006-11-29 | Servier Lab | Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route |
FR2885807B1 (fr) * | 2005-05-18 | 2008-05-16 | Mg Pharma | Composition pharmaceutique solide a liberation prolongee de 1-(2,3,4-trimethoxybenzyl) piperazine, et procede de preparation |
CZ300307B6 (cs) * | 2006-01-04 | 2009-04-15 | Zentiva, A. S. | Tableta s obsahem trimetazidinu nebo jeho farmakologicky akceptovatelné soli s modifikovaným uvolnováním |
EA009776B1 (ru) * | 2006-07-18 | 2008-04-28 | Мераб Ревазович Кокеладзе | Способ изготовления таблетированной лекарственной формы триметазидина дигидрохлорида и ее состав |
EA009810B1 (ru) * | 2006-12-26 | 2008-04-28 | Закрытое Акционерное Общество "Канонфарма Продакшн" | Матрица для изготовления таблетированной лекарственной формы и способ лечения |
EP2200591A2 (en) * | 2007-09-11 | 2010-06-30 | Ranbaxy Laboratories Limited | Controlled release pharmaceutical dosage forms of trimetazidine |
JP2012515757A (ja) | 2009-01-20 | 2012-07-12 | マイクロ ラブス リミテッド | トリメタジジンの放出調節固形薬剤組成物及びその製造方法 |
HUE027498T2 (en) * | 2009-01-30 | 2016-10-28 | Lupin Ltd | Pharmaceutical preparations containing trimetazidine |
TR201001902A2 (tr) | 2010-03-12 | 2011-04-21 | Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. | Uzatılmış salınımlı trimetazidin tablet |
RU2445958C2 (ru) * | 2010-04-20 | 2012-03-27 | Общество с ограниченной ответственностью "Озон" (ООО "Озон") | Матричная таблетка с основой для пролонгированного высвобождения триметазидина и способ ее изготовления |
ES2508490T3 (es) | 2010-05-04 | 2014-10-16 | Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi | Formulación de trimetazidina con diferentes perfiles de liberación |
EP2386302A1 (en) | 2010-05-11 | 2011-11-16 | Ranbaxy Laboratories Limited | A controlled release pharmaceutical dosage form of trimetazidine and processes for the preparation thereof |
EP2491930A1 (en) | 2011-02-25 | 2012-08-29 | Deva Holding Anonim Sirketi | Pharmaceutical combination of betahistine and trimetazidine |
FR2978916B1 (fr) * | 2011-08-10 | 2013-07-26 | Servier Lab | Composition pharmaceutique solide pour administration buccale d'agomelatine |
FR2986431B1 (fr) * | 2012-02-03 | 2017-03-17 | Servier Lab | Composition pharmaceutique a liberation prolongee de trimetazidine, son procede de fabrication et son utilisation dans des traitements therapeutiques |
CN102824644B (zh) * | 2012-09-13 | 2013-12-25 | 浙江诚意药业有限公司 | 使用羟丙基纤维素制备的高稳定性的缓释片 |
KR20160118733A (ko) | 2015-04-03 | 2016-10-12 | 이인현 | 호스 권취용 호스 안내장치 및 이를 구비한 호스 권취기 |
CN109316455B (zh) * | 2017-07-31 | 2021-05-25 | 北京福元医药股份有限公司 | 一种盐酸曲美他嗪缓释片 |
CN109908096A (zh) * | 2017-12-12 | 2019-06-21 | 武汉武药科技有限公司 | 一种盐酸曲美他嗪缓释片及其制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4226849A (en) * | 1979-06-14 | 1980-10-07 | Forest Laboratories Inc. | Sustained release therapeutic compositions |
FR2490963B1 (fr) * | 1980-09-30 | 1986-04-18 | Science Union & Cie | Nouvelle composition therapeutique a action anti-ischemique contenant de la trimethoxy 2, 3, 4-benzyl 1-piperazine |
KR850006132A (ko) * | 1984-02-29 | 1985-10-02 | 진 크라메르, 한스 루돌프 하우스 | 브로모크립틴 조성물 |
JPS61293931A (ja) * | 1985-06-24 | 1986-12-24 | Teijin Ltd | 徐放性医薬品組成物 |
JPH0625055B2 (ja) * | 1985-03-18 | 1994-04-06 | 日本ケミフア株式会社 | 持続性錠剤 |
EP0207638B1 (en) † | 1985-06-04 | 1990-12-19 | Teijin Limited | Sustained-release pharmaceutical preparation |
SE455836B (sv) * | 1985-10-11 | 1988-08-15 | Haessle Ab | Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning |
SE8601624D0 (sv) * | 1986-04-11 | 1986-04-11 | Haessle Ab | New pharmaceutical preparations |
FR2677886B1 (fr) * | 1991-06-18 | 1995-03-31 | Adir | Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale. |
FR2681324B1 (fr) * | 1991-09-18 | 1993-10-29 | Adir Cie | Nouveaux derives de la trimetazidine, leur procede de preparation et les compositions pharmaceutiques les contenant. |
KR940021051A (ko) * | 1993-03-03 | 1994-10-17 | 손정삼 | 3단계 약물방출형 지속성 정제 |
RU2082400C1 (ru) * | 1993-12-16 | 1997-06-27 | Акционерное общество - Фармацевтическая фирма "Ник-Фарм" | Способ получения нитроглицерина пролонгированного действия |
FR2717687B1 (fr) * | 1994-03-24 | 1996-06-14 | Adir | Compositions pharmaceutiques permettant la libération prolongée de trimétazidine après administration par voie orale. |
-
1999
- 1999-12-17 FR FR9915960A patent/FR2802424B1/fr not_active Expired - Fee Related
-
2000
- 2000-12-11 JP JP2000375812A patent/JP2001172181A/ja active Pending
- 2000-12-14 AU AU72285/00A patent/AU780011B2/en not_active Expired
- 2000-12-14 MX MXPA00012462A patent/MXPA00012462A/es active IP Right Grant
- 2000-12-14 IT IT2000RM000667A patent/IT1317075B1/it active
- 2000-12-14 CY CY0000059A patent/CY2347B1/xx unknown
- 2000-12-15 LU LU90700A patent/LU90700B1/fr active
- 2000-12-15 OA OA1200200181A patent/OA12121A/en unknown
- 2000-12-15 DE DE60020501.0T patent/DE60020501T3/de not_active Expired - Lifetime
- 2000-12-15 CZ CZ20022082A patent/CZ299461B6/cs not_active IP Right Cessation
- 2000-12-15 NZ NZ508912A patent/NZ508912A/en not_active IP Right Cessation
- 2000-12-15 KR KR10-2000-0076962A patent/KR100456933B1/ko active IP Right Review Request
- 2000-12-15 ZA ZA200007548A patent/ZA200007548B/xx unknown
- 2000-12-15 GE GE4838A patent/GEP20053540B/en unknown
- 2000-12-15 AT AT00403533T patent/ATE296622T1/de active
- 2000-12-15 PT PT00403533T patent/PT1108424E/pt unknown
- 2000-12-15 DK DK00403533.3T patent/DK1108424T4/da active
- 2000-12-15 UA UA2002075914A patent/UA80087C2/uk unknown
- 2000-12-15 GR GR20000100433A patent/GR1003658B/el unknown
- 2000-12-15 PL PL344564A patent/PL206994B1/pl not_active IP Right Cessation
- 2000-12-15 WO PCT/FR2000/003546 patent/WO2001043747A1/fr active IP Right Grant
- 2000-12-15 HU HU0004966A patent/HU226956B1/hu active IP Right Maintenance
- 2000-12-15 ES ES00403533.3T patent/ES2240033T5/es not_active Expired - Lifetime
- 2000-12-15 PT PT102542A patent/PT102542A/pt not_active IP Right Cessation
- 2000-12-15 SI SI200030704T patent/SI1108424T2/sl unknown
- 2000-12-15 CN CNB001380605A patent/CN1166408C/zh not_active Expired - Lifetime
- 2000-12-15 IE IE20001017A patent/IE20001017A1/en not_active Application Discontinuation
- 2000-12-15 SK SK863-2002A patent/SK286752B6/sk not_active IP Right Cessation
- 2000-12-15 AR ARP000106662A patent/AR026968A1/es not_active Application Discontinuation
- 2000-12-15 ES ES200003018A patent/ES2176106B1/es not_active Expired - Fee Related
- 2000-12-15 EP EP00403533.3A patent/EP1108424B2/fr not_active Expired - Lifetime
- 2000-12-18 EA EA200001201A patent/EA008223B1/ru not_active IP Right Cessation
- 2000-12-18 EA EA200501901A patent/EA200501901A1/ru unknown
- 2000-12-18 BR BR0005915-3A patent/BR0005915A/pt not_active Application Discontinuation
-
2001
- 2001-11-12 HK HK01107928A patent/HK1036937A1/xx not_active IP Right Cessation
-
2002
- 2002-07-16 BG BG106927A patent/BG65773B1/bg unknown
-
2007
- 2007-08-31 JP JP2007224959A patent/JP2007314578A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK286752B6 (sk) | Matricová tableta na predĺžené uvoľňovanie trimetazidínu a spôsob jej prípravy | |
EP1110543B1 (en) | Extended release oral dosage composition | |
EP1340495B1 (en) | Extended release tablet of clarithromycin | |
EP0840603B1 (en) | Pharmaceutical composition of l-dopa ethyl ester | |
US20030175341A1 (en) | Controlled release formulation | |
US20060039969A1 (en) | Extended release formulations of erythromycin derivatives | |
EP1458377B1 (en) | Tegaserod pharmaceutical compositions | |
US20050064033A1 (en) | Extended release formulations of erythromycin derivatives | |
US20020123503A1 (en) | Cabergoline pharmaceutical compositions and methods of use thereof | |
US20040127541A1 (en) | Bicifadine formulation | |
EP2802311B1 (en) | Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof | |
PL191767B1 (pl) | Stabilizowane przed racemizacją stałe lub ciekłe preparaty farmaceutyczne zawierające jako składnik czynny cilansetron, sposób wytwarzania stabilizowanych przed racemizacją stałych preparatów farmaceutycznych zawierających jako składnik czynny cilansetron oraz zastosowanie dopuszczalnych fizjologicznie rozpuszczalnych w wodzie kwaśnych dodatków | |
US20080008751A1 (en) | Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof | |
WO2020148219A1 (en) | A method of manufacturing a pharmaceutical composition comprising nefopam and acetaminophen, and the pharmaceutical composition obtained thereby | |
EP3911305B1 (en) | A method of manufacturing a pharmaceutical composition comprising nefopam and acetaminophen, and the pharmaceutical composition obtained thereby | |
KR102027912B1 (ko) | 경구투여용 탐술로신 또는 이의 약제학적으로 허용되는 염을 포함하는 서방성 삼중정제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4A | Expiry of patent |
Expiry date: 20201215 |